Neurocrine Biosciences Inc (NBIX) — Net Asset Quality Index
Neurocrine Biosciences Inc (NBIX) has a Net Asset Quality Index of 70.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $4.63 Billion minus total liabilities of $1.38 Billion yields net assets of $3.25 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check NBIX asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Neurocrine Biosciences Inc Net Asset Quality Index Over Time (1996–2025)
This chart shows how Neurocrine Biosciences Inc's Net Asset Quality Index has evolved across 30 annual periods from 1996 to 2025. As of December 2025, the index stands at 70.2%, representing net assets of $3.25 Billion against total assets of $4.63 Billion USD. See Neurocrine Biosciences Inc (NBIX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Neurocrine Biosciences Inc (1996–2025)
The table below presents the year-by-year Net Asset Quality Index for Neurocrine Biosciences Inc from 1996 to 2025, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see NBIX company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 70.2% | $3.25 Billion | $4.63 Billion | $1.38 Billion | ▲ +0.6 pp |
| 2024 | 69.6% | $2.59 Billion | $3.72 Billion | $1.13 Billion | ▲ +1.0 pp |
| 2023 | 68.6% | $2.23 Billion | $3.25 Billion | $1.02 Billion | ▼ -3.5 pp |
| 2022 | 72.1% | $1.71 Billion | $2.37 Billion | $660.90 Million | ▲ +5.8 pp |
| 2021 | 66.3% | $1.37 Billion | $2.07 Billion | $698.50 Million | ▲ +1.4 pp |
| 2020 | 64.9% | $1.13 Billion | $1.73 Billion | $608.50 Million | ▲ +16.2 pp |
| 2019 | 48.8% | $636.90 Million | $1.31 Billion | $669.10 Million | ▲ +0.4 pp |
| 2018 | 48.4% | $480.76 Million | $993.15 Million | $512.39 Million | ▲ +2.9 pp |
| 2017 | 45.5% | $372.14 Million | $817.59 Million | $445.45 Million | ▼ -40.7 pp |
| 2016 | 86.2% | $314.88 Million | $365.09 Million | $50.21 Million | ▼ -3.2 pp |
| 2015 | 89.4% | $424.45 Million | $474.79 Million | $50.33 Million | ▲ +3.5 pp |
| 2014 | 85.9% | $208.70 Million | $243.03 Million | $34.33 Million | ▲ +8.0 pp |
| 2013 | 77.8% | $120.41 Million | $154.68 Million | $34.27 Million | ▼ -0.9 pp |
| 2012 | 78.8% | $154.37 Million | $195.98 Million | $41.61 Million | ▲ +35.3 pp |
| 2011 | 43.4% | $60.08 Million | $138.37 Million | $78.29 Million | ▲ +30.0 pp |
| 2010 | 13.4% | $19.34 Million | $144.42 Million | $125.08 Million | ▲ +7.8 pp |
| 2009 | 5.6% | $3.95 Million | $70.82 Million | $66.86 Million | ▼ -25.5 pp |
| 2008 | 31.1% | $36.77 Million | $118.18 Million | $81.41 Million | ▼ -11.8 pp |
| 2007 | 42.9% | $118.70 Million | $276.65 Million | $157.96 Million | ▼ -37.9 pp |
| 2006 | 80.8% | $314.72 Million | $389.68 Million | $74.96 Million | ▲ +0.0 pp |
| 2005 | 80.7% | $390.10 Million | $483.12 Million | $93.02 Million | ▲ +4.9 pp |
| 2004 | 75.9% | $393.83 Million | $519.22 Million | $125.39 Million | ▲ +5.4 pp |
| 2003 | 70.5% | $391.12 Million | $554.96 Million | $163.84 Million | ▼ -13.7 pp |
| 2002 | 84.1% | $224.25 Million | $266.54 Million | $42.28 Million | ▼ -5.5 pp |
| 2001 | 89.6% | $310.39 Million | $346.35 Million | $35.96 Million | ▲ +1.9 pp |
| 2000 | 87.8% | $163.21 Million | $185.96 Million | $22.75 Million | ▼ -0.5 pp |
| 1999 | 88.3% | $96.40 Million | $109.20 Million | $12.80 Million | ▼ -1.2 pp |
| 1998 | 89.4% | $72.00 Million | $80.50 Million | $8.50 Million | ▼ -1.1 pp |
| 1997 | 90.5% | $83.20 Million | $91.90 Million | $8.70 Million | ▼ -2.8 pp |
| 1996 | 93.3% | $72.80 Million | $78.00 Million | $5.20 Million | — |